Second, Li et al. demonstrated that metformin treatment in diabetic patients with ovarian cancer was associated with reduced circulating MDSCs, a concomitant increase in the circulating CD8+ T cells, and longer survival [29]. This evidence concerns the gene CD8A and ovarian carcinoma.